No Data
Express News | Huiyu Pharmaceutical: Injection grade Amrinone, Metronidazole Sodium Chloride Injection obtained pharmaceutical registration certificate.
Huiyu Pharma Gets Nod to Initiate Clinical Trials For Drug Candidate HY-2003
Express News | Huiyu Pharmaceuticals: The clinical trial application for HY-2003 independently developed by the company has been approved.
Huiyu Pharmaceutical's Unit Gets Nod to Market Two Drugs in UK; Shares Jump 5%
The A-share innovative drugs sector surged, hainan huluwa pharmaceutical group reached its maximum increase.
Greelonghui November 26th | Hainan Huluwa pharmaceutical group hit the limit up, Huayu Pharmaceutical rose more than 7%, Sailong Pharmaceutical Group, Betta Pharmaceuticals, Shanghai Allist Pharmaceuticals Co., Ltd., and others followed the upward trend.
Huiyu Pharmaceutical (688553.SH): Injection voriconazole, fluconazole group injection solution obtained marketing authorization in the united kingdom.
On November 25, Gelonghui reported that Huiyu Pharmaceuticals (688553.SH) announced that its wholly-owned subsidiary Seacross Pharmaceuticals Ltd. recently received marketing authorization from the united kingdom's Medicines and Healthcare products Regulatory Agency for its injectable Voriconazole and Fluvestrant Injection products. Injectable Voriconazole is a broad-spectrum triazole antifungal agent primarily used to treat invasive aspergillosis; to treat severe invasive infections caused by Candida resistant to Fluconazole (including Candida krusei); and to treat severe fungal infections caused by the genera Nocardia and Fusarium.
No Data
No Data